Meningococcal Group B OMV vaccine

B群脑膜炎球菌OMV疫苗

Report date: 2026/04/07 20:00:20

Base Information

Drug NameMeningococcal Group B OMV vaccine

Drug Alias NameDX-104

ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningococcal InfectionsMeningitis, Meningococcal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustraliaMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesDelonix Bioworks Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDelonix Bioworks Ltd

Inactive CompaniesN/A

Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal

Inactive IndicationsN/A

Other Information

ATC CodeN/A